JUSTIN HARRICHARRAN: Open Payments
NPI 1477179612 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$803 in 35 payments from 8 companies in 2025. Trend: 2023 $464 · 2024 $703 · 2025 $803
Food & beverage: $692Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $270 |
| Teva Pharmaceuticals USA, Inc. | 8 | $205 |
| Almatica Pharma LLC | 4 | $83 |
| Orexo US, Inc. | 4 | $79 |
| ViiV Healthcare Company | 2 | $53 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Gilead Sciences, Inc. | 2 | $42 |
| Indivior Inc. | 1 | $25 |
Products named: VRAYLAR, UZEDY, LOREEV XR, Zubsolv, APRETUDE, SPRAVATO, SUBLOCADE, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
